abstract |
New heterocyclic compounds of formula I wherein R, R, R, R, R, R, R, R, R and R are as defined in claim 1, are glucokinase activators and can be used to prevent and / or treat type 1 and type 2 diabetes, obesity, neuropathy and / or nephropathy. |